Linked Data API

Show Search Form

Search Results

1126307
star this property registered interest false more like this
star this property date less than 2019-05-13more like thismore than 2019-05-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Civil Proceedings more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government how much money the NHS spent as part of legal settlements in each year from 2009 to 2018; and how much of each year's spend relates to legal fees. more like this
star this property tabling member printed
Baroness Hodgson of Abinger more like this
star this property uin HL15667 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-24more like thismore than 2019-05-24
star this property answer text <p>NHS Resolution has provided the following information:</p><p>NHS Resolution has provided tables which cover:</p><p>- total expenditure for NHS Resolution Clinical Negligence Schemes and NHS Resolution non-clinical negligence schemes from 2009 to 2018;</p><p>- the total legal costs per financial year; and</p><p>- the draft budget for legal fees/damages 2019 for NHS Resolution Clinical Negligence Schemes and NHS Resolution non-clinical negligence schemes.</p><p>The data is attached due to the size of the data.</p><p>National Health Service spend on legal fees for matters other than clinical/non-clinical negligence settlements since 2009 has been interpreted as spend relating to NHS providers and commissioners.</p><p>This includes NHS trusts, NHS foundation trusts and NHS England and clinical commissioning groups. NHS spend on legal fees for non-negligence matters is shown in the following table.</p><table><tbody><tr><td><p>Year</p></td><td><p>Total legal fees (£000s)</p></td></tr><tr><td><p>2013-14</p></td><td><p>110,747</p></td></tr><tr><td><p>2014-15</p></td><td><p>171,806</p></td></tr><tr><td><p>2015-16</p></td><td><p>162,273</p></td></tr><tr><td><p>2016-17</p></td><td><p>172,135</p></td></tr><tr><td><p>2017-18</p></td><td><p>160,140</p></td></tr></tbody></table><p>Prior to 2013-14, expenditure on legal fees was not separately classified by primary care trusts and strategic health authorities who both carried out NHS commissioning and NHS trusts. Therefore, comparable information pre 2013-14 is unavailable.</p><p>There is no specific category of expenditure that isolates spend relating to legal settlements in the NHS.</p><p>We have interpreted the request for data for the amounts set aside in 2019 as the value of said provisions as at the end of the financial year, 31 March 2019. This data is still subject to audit and will not be available until after publication of the Annual Report and Accounts in July 2019.</p><p>The budget totals for legal fees relating to NHS spend in 2019 is not available.</p><p> </p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL15668 more like this
star this property question first answered
less than 2019-05-24T11:47:45.193Zmore like thismore than 2019-05-24T11:47:45.193Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property attachment
1
star this property file name HL15667 & HL15668 Data.docx more like this
star this property title HL15667_HL15668_data more like this
star this property tabling member
4301
unstar this property label Biography information for Baroness Hodgson of Abinger more like this
1126308
star this property registered interest false more like this
star this property date less than 2019-05-13more like thismore than 2019-05-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Civil Proceedings more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government how much money the NHS has set aside for potential legal settlements in 2019; and how much they have budgeted for legal fees. more like this
star this property tabling member printed
Baroness Hodgson of Abinger more like this
star this property uin HL15668 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-24more like thismore than 2019-05-24
star this property answer text <p>NHS Resolution has provided the following information:</p><p>NHS Resolution has provided tables which cover:</p><p>- total expenditure for NHS Resolution Clinical Negligence Schemes and NHS Resolution non-clinical negligence schemes from 2009 to 2018;</p><p>- the total legal costs per financial year; and</p><p>- the draft budget for legal fees/damages 2019 for NHS Resolution Clinical Negligence Schemes and NHS Resolution non-clinical negligence schemes.</p><p>The data is attached due to the size of the data.</p><p>National Health Service spend on legal fees for matters other than clinical/non-clinical negligence settlements since 2009 has been interpreted as spend relating to NHS providers and commissioners.</p><p>This includes NHS trusts, NHS foundation trusts and NHS England and clinical commissioning groups. NHS spend on legal fees for non-negligence matters is shown in the following table.</p><table><tbody><tr><td><p>Year</p></td><td><p>Total legal fees (£000s)</p></td></tr><tr><td><p>2013-14</p></td><td><p>110,747</p></td></tr><tr><td><p>2014-15</p></td><td><p>171,806</p></td></tr><tr><td><p>2015-16</p></td><td><p>162,273</p></td></tr><tr><td><p>2016-17</p></td><td><p>172,135</p></td></tr><tr><td><p>2017-18</p></td><td><p>160,140</p></td></tr></tbody></table><p>Prior to 2013-14, expenditure on legal fees was not separately classified by primary care trusts and strategic health authorities who both carried out NHS commissioning and NHS trusts. Therefore, comparable information pre 2013-14 is unavailable.</p><p>There is no specific category of expenditure that isolates spend relating to legal settlements in the NHS.</p><p>We have interpreted the request for data for the amounts set aside in 2019 as the value of said provisions as at the end of the financial year, 31 March 2019. This data is still subject to audit and will not be available until after publication of the Annual Report and Accounts in July 2019.</p><p>The budget totals for legal fees relating to NHS spend in 2019 is not available.</p><p> </p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL15667 more like this
star this property question first answered
remove maximum value filtermore like thismore than 2019-05-24T11:47:45.257Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property attachment
1
star this property file name HL15667 & HL15668 Data.docx more like this
star this property title HL15667_HL15668_data more like this
star this property tabling member
4301
unstar this property label Biography information for Baroness Hodgson of Abinger more like this
1125504
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Pneumococcal Diseases: Vaccination more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of the recommendations by the Joint Committee on Vaccination and Immunisation to reduce the infant pneumococcal vaccination schedule from three doses to two. more like this
star this property tabling member printed
Baroness Masham of Ilton more like this
star this property uin HL15599 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) provides independent expert advice on the United Kingdom’s immunisation programme. As an independent committee, it is well placed to ensure the latest and most appropriate evidence has been considered on potential changes to scheduling within the vaccine programme. It bases its advice on review of a wide range of scientific and other evidence, including from the published literature, commissioned studies such as independent analyses of vaccine effectiveness and cost effectiveness.</p><p>The JCVI advised that a two-dose schedule for the infant pneumococcal conjugate vaccine (PCV) Prevenar13 is appropriate for the UK. Its advice takes into account the public health aspects of any potential change to the vaccination schedule, such as the potential impact on cases of infectious disease. The JCVI consulted relevant stakeholders on its proposed advice, between January and April 2018, to ensure that its advice reflects all the evidence.</p><p>The JCVI’s advice on the infant pneumococcal programme was given full consideration, including the potential public health implications, before a decision was made to implement it. The UK frequently adopts innovative immunisation schedules and we regularly change the vaccine schedule following the advice of our independent expert committee, as we are doing in this case.</p><p>The decision is based on the excellent effectiveness of the vaccine and years of high uptake, which has helped to provide protection to the rest of the population and has successfully controlled many types of pneumococcal disease in this country. The evidence shows that two doses will sustain the excellent results we have already seen. We are confident that the world-class disease surveillance system we have in this country means our expert committee can closely monitor the impact of this change. This is set out in the JCVI’s minutes which are attached.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL15600 more like this
star this property question first answered
less than 2019-05-22T14:50:14.54Zmore like thismore than 2019-05-22T14:50:14.54Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property attachment
1
star this property file name JCVI Minute 2015 10 Attached to HL16000 and 15999.pdf more like this
star this property title JCVI Minute 2015 more like this
star this property tabling member
1850
unstar this property label Biography information for Baroness Masham of Ilton more like this
1125505
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Pneumococcal Diseases: Vaccination more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what analyses they have conducted of the risks and benefits of reducing the infant pneumococcal vaccination schedule from 2+1 to 1+1; and whether they will publish the results any such analyses. more like this
star this property tabling member printed
Baroness Masham of Ilton more like this
star this property uin HL15600 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) provides independent expert advice on the United Kingdom’s immunisation programme. As an independent committee, it is well placed to ensure the latest and most appropriate evidence has been considered on potential changes to scheduling within the vaccine programme. It bases its advice on review of a wide range of scientific and other evidence, including from the published literature, commissioned studies such as independent analyses of vaccine effectiveness and cost effectiveness.</p><p>The JCVI advised that a two-dose schedule for the infant pneumococcal conjugate vaccine (PCV) Prevenar13 is appropriate for the UK. Its advice takes into account the public health aspects of any potential change to the vaccination schedule, such as the potential impact on cases of infectious disease. The JCVI consulted relevant stakeholders on its proposed advice, between January and April 2018, to ensure that its advice reflects all the evidence.</p><p>The JCVI’s advice on the infant pneumococcal programme was given full consideration, including the potential public health implications, before a decision was made to implement it. The UK frequently adopts innovative immunisation schedules and we regularly change the vaccine schedule following the advice of our independent expert committee, as we are doing in this case.</p><p>The decision is based on the excellent effectiveness of the vaccine and years of high uptake, which has helped to provide protection to the rest of the population and has successfully controlled many types of pneumococcal disease in this country. The evidence shows that two doses will sustain the excellent results we have already seen. We are confident that the world-class disease surveillance system we have in this country means our expert committee can closely monitor the impact of this change. This is set out in the JCVI’s minutes which are attached.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL15599 more like this
star this property question first answered
less than 2019-05-22T14:50:14.483Zmore like thismore than 2019-05-22T14:50:14.483Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property attachment
1
star this property file name JCVI Minute 2015 10 Attached to HL16000 and 15999.pdf more like this
star this property title JCVI Minute 2015 more like this
star this property tabling member
1850
unstar this property label Biography information for Baroness Masham of Ilton more like this
1125506
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading HIV Infection: Vaccination more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what steps they are taking to improve vaccination coverage for people living with HIV. more like this
star this property tabling member printed
Baroness Masham of Ilton more like this
star this property uin HL15601 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>Public Health England, in partnership with NHS England and the Department, is taking steps to improve vaccination coverage in England, including for people living with HIV.</p><p>These steps include initiatives to improve access to the immunisation programme; communication with the public; data to identify underserved individuals and populations; and training for healthcare professionals, changes to vaccination eligibility criteria; launching disease elimination strategies; running targeted social media campaigns; providing information leaflets in multiple languages and running e-learning programme for healthcare practitioners.</p><p>Certain vaccines are delivered through sexual health services that particularly benefit people living with HIV. This includes vaccines for hepatitis A, hepatitis B and human papillomavirus. People living with HIV are in the influenza risk groups and are invited for the flu vaccine on an annual basis.</p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-05-22T14:50:46.107Zmore like thismore than 2019-05-22T14:50:46.107Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1850
unstar this property label Biography information for Baroness Masham of Ilton more like this
1124901
star this property registered interest false more like this
star this property date less than 2019-05-07more like thismore than 2019-05-07
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Nusinersen more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what discussions they have had with (1) NICE, (2) NHS England, and (3) Biogen, on a Managed Access Agreement for Spinal Muscular Atrophy treatment, Spinraza. more like this
star this property tabling member printed
Baroness Thomas of Winchester more like this
star this property uin HL15576 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-17more like thismore than 2019-05-17
star this property answer text <p>Departmental officials are in regular contact with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England about a range of issues, including progress in discussions about a potential managed access agreement for Spinraza (nusinersen). Ministers have also held meetings with Biogen, NICE and NHS England on a number of occasions, at which the availability of Spinraza was discussed.</p><p>NHS England and NICE have made stakeholders and the public aware of the outcome of its appraisal committee meeting and NICE is now able to recommend the use of Spinraza for National Health Service patients in England, subject to a managed access agreement agreed between NHS England and Biogen. The final appraisal document will be published in due course.</p><p> </p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL15577 more like this
star this property question first answered
less than 2019-05-17T11:07:46.62Zmore like thismore than 2019-05-17T11:07:46.62Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
3785
unstar this property label Biography information for Baroness Thomas of Winchester more like this
1124902
star this property registered interest false more like this
star this property date less than 2019-05-07more like thismore than 2019-05-07
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading National Institute for Health and Care Excellence more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government when they estimate that NICE will publish the outcome of the NICE Evaluation Committee meeting held on 6 March. more like this
star this property tabling member printed
Baroness Thomas of Winchester more like this
star this property uin HL15577 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-17more like thismore than 2019-05-17
star this property answer text <p>Departmental officials are in regular contact with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England about a range of issues, including progress in discussions about a potential managed access agreement for Spinraza (nusinersen). Ministers have also held meetings with Biogen, NICE and NHS England on a number of occasions, at which the availability of Spinraza was discussed.</p><p>NHS England and NICE have made stakeholders and the public aware of the outcome of its appraisal committee meeting and NICE is now able to recommend the use of Spinraza for National Health Service patients in England, subject to a managed access agreement agreed between NHS England and Biogen. The final appraisal document will be published in due course.</p><p> </p> more like this
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property grouped question UIN HL15576 more like this
star this property question first answered
less than 2019-05-17T11:07:46.673Zmore like thismore than 2019-05-17T11:07:46.673Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
3785
unstar this property label Biography information for Baroness Thomas of Winchester more like this
1125835
star this property registered interest false more like this
star this property date less than 2019-05-09more like thismore than 2019-05-09
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Dental Health: Antibiotics more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 4 December 2018 (HL11750), how many antibiotic prescriptions were issued by general dental practitioners in England in 2018. more like this
star this property tabling member printed
Lord Colwyn more like this
star this property uin HL15625 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The Dental Prescribing Dashboard developed by the NHS Business Services Authority and Public Health England, includes data for National Health Service local area teams. Latest available data show general dental practitioners issued 2,912,579 prescriptions for all antimicrobials including antibiotics during April 2017 to March 2018. There were 715,545 prescriptions between January and March 2018. The Dental Prescribing Dashboard will be refreshed in summer 2019.</p><p>Analysis is based on items prescribed by NHS dentists, but some patients may attend a general medical practice with a dental infection and receive a prescription from their general practitioner (GP). These prescriptions are not included, as we cannot determine the reason why a GP prescribed antibiotics.</p><p>The <em>English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2018</em> provides information on NHS dental prescribing in dental practices and consultations. The ESPAUR report for 2019 scheduled for publication later this year will publish data for the 2018 calendar year. The ESPAUR 2018 report is attached.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-05-22T14:52:22.64Zmore like thismore than 2019-05-22T14:52:22.64Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property attachment
1
star this property file name ESPAUR_2018_report.pdf more like this
star this property title ESPAUR_2018_report more like this
star this property tabling member
3394
unstar this property label Biography information for Lord Colwyn more like this
1126321
star this property registered interest false more like this
star this property date less than 2019-05-13more like thismore than 2019-05-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Gender Dysphoria: Children more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether they intend to publish the results of the research project started in 2011 by the NHS Gender Identity Development Service Early pubertal suppression in a carefully selected group of adolescents with gender identity disorder; and if not, whether they will arrange for the data gathered by that study to be made available to other researchers. more like this
star this property tabling member printed
Lord Lucas more like this
star this property uin HL15681 more like this
star this property answer
answer
star this property is ministerial correction true more like this
star this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The research is an ethically approved study being carried out by the Tavistock and Portman NHS Foundation Trust since 2011, which is the largest provider of services for the alleviation of gender dysphoria in the United Kingdom.</p><p>The study will evaluate early pubertal suppression in a carefully selected group of adolescents with a clinical diagnosis of gender dysphoria. There are 44 young people taking part in the study.</p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish the data <ins class="ministerial">on the blocker and cross-sex hormones, for those who were appropriate for this, as</ins><del class="ministerial">once</del> all of the young people in the study have reached <ins class="ministerial">this</ins><del class="ministerial">the</del> stage<ins class="ministerial">.</ins> <del class="ministerial">when a clinical decision is made about moving from pubertal suppressants to cross-sex hormones, which the Trust expects to occur in the next 12 months.</del></p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-05-22T14:51:30.447Zmore like thismore than 2019-05-22T14:51:30.447Z
star this property question first ministerially corrected
less than 2019-07-31T15:30:59.74Zmore like thismore than 2019-07-31T15:30:59.74Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property previous answer version
119577
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1879
unstar this property label Biography information for Lord Lucas more like this
1125517
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Migrant Workers more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what plans they have, if any, to increase the number of NHS staff recruited from EU member states after Brexit. more like this
star this property tabling member printed
Lord Taylor of Warwick more like this
star this property uin HL15612 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-22more like thismore than 2019-05-22
star this property answer text <p>The Government recognises the need to be able to recruit effectively from abroad and the Immigration White Paper, <em>The UK’s future skills-based immigration system</em>, published in December 2018, sets out the foundation for a single immigration system, where it is workers’ skills that matter, not where they come from. This system will streamline the high-skilled visa route, by removing the Resident Labour Market Test and the Tier 2 Visa Cap. The Home Office is undertaking a programme of engagement to discuss the proposed measures with colleagues across Government and industry, to develop a future immigration system that works for the whole of the United Kingdom.</p><p>The Government wants to support the National Health Service in expanding international recruitment more widely, as this clearly has a role to play to meeting staffing shortages, especially in the short term. Recruitment of doctors and nurses is the responsibility of individual NHS organisations, a number of which do actively recruit from overseas, including from countries in the European Union. However, we also recognise the need to boost our domestic workforce as well. The NHS Long Term Plan sets out a vital strategic framework to ensure that, over the next 10 years, the NHS will have the staff it needs so that nurses and doctors are working in a supportive culture that allows them to provide the expert compassionate care they are committed to providing. Details of this will be explored more fully in the forthcoming Interim NHS People Plan.</p><p>The Government has taken steps to ensure that EU citizens can continue to come and work in the NHS once we have left the EU. In March 2019, we put in place legislation that ensures the continued recognition of qualifications from EU countries by all professional regulators covering the health and social care sectors. This means that EU citizens will continue to be able to come and practice in the UK once we have left the EU, even if we leave without a deal.</p>
star this property answering member printed Baroness Blackwood of North Oxford more like this
star this property question first answered
less than 2019-05-22T14:54:38.56Zmore like thismore than 2019-05-22T14:54:38.56Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1796
unstar this property label Biography information for Lord Taylor of Warwick more like this